The global microarray market size was USD 3.99 Billion in 2021 and is expected to register a revenue CAGR of 8.31% during the forecast period, according to latest analysis by Emergen Research. Increasing use of microarrays for diagnosis of genetic disorders and infectious diseases is a crucial factor driving market revenue growth.
Microarray is a key technology used in molecular biology for early detection of cancer, such as breast cancer and ovarian cancer by detecting mutations in genes, which may give rise to the disease. Rising incidence of breast cancer is a major factor contributing to revenue growth of the market. According to statistics of World Health Organization (WHO), around 2.3 million women were diagnosed with breast cancer and 685,000 patients died globally because of cancer, in 2020.
DNA microarrays enable easy and early detection of mutated genes, therefore allowing patients to obtain early treatment, which is increasing demand for system. Recently, researchers have developed coronavirus variant-based microarray platforms for estimating efficacy of vaccines developed against pathogen.
To know more about the report @ https://www.emergenresearch.com/industry-report/microarray-market
Some major companies operating in the global market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Merck KGaA, PerkinElmer Inc., Arrayit Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., RayBiotech Life, Inc., Full Moon BioSystems, Inc., and CapitalBio Technology Co., Ltd.
The global Microarray Market is broadly segmented on the basis of different product types, application range, end-use industries, key regions, and an intensely competitive landscape. This section of the report is solely targeted at readers looking to select the most appropriate and lucrative segments of the Microarray Market sector in a strategic manner. The segmental analysis also helps companies interested in this sector make optimal business decisions and achieve their desired goals.
Emergen Research has segmented the global microarray market based on type, product, application, end-use, and region:
Type Outlook (Revenue, USD Billion; 2019-2030)
DNA Microarray
cDNA Microarray
BAC Microarray
SNP Microarray
Oligo Microarray
Protein Microarray
Analytical Protein Microarray
Functional Protein Microarray
Reverse-Phase Protein Microarray
Peptide Microarray
Product Outlook (Revenue, USD Billion; 2019-2030)
Consumables
Software and Services
Instruments
Others
Application Outlook (Revenue, USD Billion; 2019-2030)
Disease Diagnosis
Cancer Genome Analysis
Drug Discovery
Genome Sequencing
Expression Analysis
Toxicological Research
Others
End-Use Outlook (Revenue, USD Billion; 2019-2030)
Pharmaceutical Industry
Biotechnology Industry
Academic and Research Laboratories
Diagnostic Centers
Others
Regional Analysis:
The report further examines the market in the key regions of the world with regard to production and consumption patterns, import/export, supply and demand ratio, revenue generation, market share and size, and presence of prominent players in the regions. The report also covers the expansion plans undertaken by companies in the regions under the regional analysis section.
Key regions in the market include:
North America
U.S.
Canada
Europe
U.K.
Italy
Germany
France
Rest of EU
Asia Pacific
India
Japan
China
South Korea
Australia
Rest of APAC
Latin America
Chile
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Saudi Arabia
U.A.E.
South Africa
Rest of MEA
Key Questions Addressed in the Report:
Who are the leading players in the Microarray industry?
Which region is expected to dominate the market in the coming years?
What are the key applications of Microarray?
Which segment is expected to garner traction during the coming years?
What are the key strategies adopted by leading players in the market?
Thank you for reading the research report. To get more information about the customized report and customization plan, kindly connect to us and we will provide you with the well-suited customized report.
About Us:
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.